Cargando…
Estimands for factorial trials
Factorial trials offer an efficient method to evaluate multiple interventions in a single trial, however the use of additional treatments can obscure research objectives, leading to inappropriate analytical methods and interpretation of results. We define a set of estimands for factorial trials, and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542167/ https://www.ncbi.nlm.nih.gov/pubmed/35751568 http://dx.doi.org/10.1002/sim.9510 |
_version_ | 1784804088516444160 |
---|---|
author | Kahan, Brennan C. Morris, Tim P. Goulão, Beatriz Carpenter, James |
author_facet | Kahan, Brennan C. Morris, Tim P. Goulão, Beatriz Carpenter, James |
author_sort | Kahan, Brennan C. |
collection | PubMed |
description | Factorial trials offer an efficient method to evaluate multiple interventions in a single trial, however the use of additional treatments can obscure research objectives, leading to inappropriate analytical methods and interpretation of results. We define a set of estimands for factorial trials, and describe a framework for applying these estimands, with the aim of clarifying trial objectives and ensuring appropriate primary and sensitivity analyses are chosen. This framework is intended for use in factorial trials where the intent is to conduct “two‐trials‐in‐one” (ie, to separately evaluate the effects of treatments A and B), and is comprised of four steps: (i) specifying how additional treatment(s) (eg, treatment B) will be handled in the estimand, and how intercurrent events affecting the additional treatment(s) will be handled; (ii) designating the appropriate factorial estimator as the primary analysis strategy; (iii) evaluating the interaction to assess the plausibility of the assumptions underpinning the factorial estimator; and (iv) performing a sensitivity analysis using an appropriate multiarm estimator to evaluate to what extent departures from the underlying assumption of no interaction may affect results. We show that adjustment for other factors is necessary for noncollapsible effect measures (such as odds ratio), and through a trial re‐analysis we find that failure to consider the estimand could lead to inappropriate interpretation of results. We conclude that careful use of the estimands framework clarifies research objectives and reduces the risk of misinterpretation of trial results, and should become a standard part of both the protocol and reporting of factorial trials. |
format | Online Article Text |
id | pubmed-9542167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95421672022-10-14 Estimands for factorial trials Kahan, Brennan C. Morris, Tim P. Goulão, Beatriz Carpenter, James Stat Med Research Articles Factorial trials offer an efficient method to evaluate multiple interventions in a single trial, however the use of additional treatments can obscure research objectives, leading to inappropriate analytical methods and interpretation of results. We define a set of estimands for factorial trials, and describe a framework for applying these estimands, with the aim of clarifying trial objectives and ensuring appropriate primary and sensitivity analyses are chosen. This framework is intended for use in factorial trials where the intent is to conduct “two‐trials‐in‐one” (ie, to separately evaluate the effects of treatments A and B), and is comprised of four steps: (i) specifying how additional treatment(s) (eg, treatment B) will be handled in the estimand, and how intercurrent events affecting the additional treatment(s) will be handled; (ii) designating the appropriate factorial estimator as the primary analysis strategy; (iii) evaluating the interaction to assess the plausibility of the assumptions underpinning the factorial estimator; and (iv) performing a sensitivity analysis using an appropriate multiarm estimator to evaluate to what extent departures from the underlying assumption of no interaction may affect results. We show that adjustment for other factors is necessary for noncollapsible effect measures (such as odds ratio), and through a trial re‐analysis we find that failure to consider the estimand could lead to inappropriate interpretation of results. We conclude that careful use of the estimands framework clarifies research objectives and reduces the risk of misinterpretation of trial results, and should become a standard part of both the protocol and reporting of factorial trials. John Wiley & Sons, Inc. 2022-06-25 2022-09-30 /pmc/articles/PMC9542167/ /pubmed/35751568 http://dx.doi.org/10.1002/sim.9510 Text en © 2022 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Kahan, Brennan C. Morris, Tim P. Goulão, Beatriz Carpenter, James Estimands for factorial trials |
title | Estimands for factorial trials |
title_full | Estimands for factorial trials |
title_fullStr | Estimands for factorial trials |
title_full_unstemmed | Estimands for factorial trials |
title_short | Estimands for factorial trials |
title_sort | estimands for factorial trials |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542167/ https://www.ncbi.nlm.nih.gov/pubmed/35751568 http://dx.doi.org/10.1002/sim.9510 |
work_keys_str_mv | AT kahanbrennanc estimandsforfactorialtrials AT morristimp estimandsforfactorialtrials AT goulaobeatriz estimandsforfactorialtrials AT carpenterjames estimandsforfactorialtrials |